Cargando…
LPPR5 Expression in Glioma Affects Growth, Vascular Architecture, and Sunitinib Resistance
Despite intensive research, glioblastoma remains almost invariably fatal. Various promising drugs targeting specific aspects of glioma biology, in addition to or as an alternative to antiproliferative chemotherapy, were not successful in larger clinical trials. Further insights into the biology of g...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952597/ https://www.ncbi.nlm.nih.gov/pubmed/35328529 http://dx.doi.org/10.3390/ijms23063108 |